Benchmark International facilitated the transaction between Solis Medical Laboratories (SML), Inc. and De Novo Diagnostics, LLC

Benchmark International has successfully facilitated the transaction between Solis Medical Laboratories (SML), Inc. and De Novo Diagnostics, LLC. SML is an independent medical laboratory that offers clinical laboratory testing, phlebotomy, and courier services. De Novo Diagnostics offers services in the field of companion diagnostics, therapeutic drug monitoring and molecular diagnostics in autoimmune diseases and cancer biology.

With experience in the field, De Novo Diagnostics, was looking for an opportunity to form a platform business in the Houston area, and SML presented that opportunity. Benchmark International worked alongside SML to obtain the best result.

Founders Cleve and Margie Stoy commented, “It was very important to have Benchmark International lead the deal for us. The team was very responsive to all our questions and would always explain everything in detail. They were involved every step of the way. The Benchmark International team remained conscious of the confidentiality of the transaction, while they were marketing the opportunity, to avoid creating any disturbances in our day to day operations.”

Benchmark International Senior Associate Luis Vinals stated “Cleve and Margie were wonderful clients to work with. They were engaging and always responsive to market enquiries. Our team’s market research, dedication, and effort resulted in sourcing a buyer that met our client’s expectations. Not only was the buyer able to meet our clients’ expectations, but the deal allowed Cleve and Margie to exit their business within their desired timeframe.”

Share This Post